UK Medtech Gets A Role In Post-Brexit Trade Deal Negotiations
Pressure ramps to broker international agreements as end of EU withdrawal period nears
Executive Summary
With the Brexit implementation period ending in four months, the UK government has launched a trade advisory group for international life sciences deal talks and given UK medtech a seat at the table.
You may also be interested in...
UKCA Mark Will Be The Post-EU Route To The British Medtech Market In January 2021
New MHRA guidance says the EU CE marking will continue to be used for devices and diagnostics in Great Britain until June 2023, and thereafter a standalone regulatory system will come into place.
UK Medtech Industry Advances Its Case For US FTA Amid Ongoing EU Talks
Securing a favorable post-Brexit free trade agreement with the US is the principal aim of the UK’s Department for International Trade, and the UK medtech industry is pressing its case for closer business links with its largest non-EU trading partner.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.